Palliative Care for People With Hepatocellular Carcinoma, and Specific Benefits for Older Adults

Christopher D. Woodrell, Lissi Hansen, Thomas D. Schiano, Nathan E. Goldstein

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Purpose: Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, has a rapidly rising prevalence in the United States and a very poor overall rate of survival. This epidemic is driven by the cohort of aging Baby Boomers with hepatitis C viral infection and the increasing prevalence of cirrhosis as a result of nonalcoholic steatohepatitis. Because curative options are limited, the disease course creates, in patients and their families, distressing uncertainty around prognosis and treatment decisions. Older adults are disproportionately affected by HCC and have more comorbidities, adding to the complexity of the disease. This population would benefit from increased access to palliative care services, which can potentially complement the treatments throughout the disease trajectory. The purpose of this review was to use existing evidence to propose a new model of palliative care integration in patients with HCC. Thus, we focus on the HCC stage and the treatment algorithm, the ways that palliative care can offer support in this population at each stage, as well as elements that can enhance patient and family support throughout the entire disease trajectory, with an emphasis on the care of older adults with HCC. Methods: This is a narrative review in which we identify evidence-based ways that palliative care can help younger and older adults with HCC and their families, at each stage of HCC and throughout the disease trajectory. Findings: We propose ways to integrate HCC and palliative care based on the existing evidence in both fields. Palliative care offers support in symptom management, advanced care planning, and decision making in ways that are specific to each stage of HCC. We also discuss the evidence that illustrates the palliative care needs of patients with HCC that span the entire course of illness, including coping with the stigmatization of liver disease, addressing informational needs at different stages, and discussing quality of life longitudinally. Implications: Integrating palliative care into the treatment of patients with HCC has the potential to improve outcomes, although more research is needed to build this evidence base.

Original languageEnglish (US)
Pages (from-to)512-525
Number of pages14
JournalClinical Therapeutics
Volume40
Issue number4
DOIs
StatePublished - Apr 1 2018

Fingerprint

Palliative Care
Hepatocellular Carcinoma
Stereotyping
Virus Diseases
Therapeutics
Liver Neoplasms
Hepatitis C
Population
Uncertainty
Comorbidity
Liver Diseases
Young Adult
Decision Making
Fibrosis
Survival Rate
Quality of Life

Keywords

  • cirrhosis
  • geriatric oncology
  • hepatocellular carcinoma
  • palliative care
  • supportive oncology

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Palliative Care for People With Hepatocellular Carcinoma, and Specific Benefits for Older Adults. / Woodrell, Christopher D.; Hansen, Lissi; Schiano, Thomas D.; Goldstein, Nathan E.

In: Clinical Therapeutics, Vol. 40, No. 4, 01.04.2018, p. 512-525.

Research output: Contribution to journalReview article

Woodrell, Christopher D. ; Hansen, Lissi ; Schiano, Thomas D. ; Goldstein, Nathan E. / Palliative Care for People With Hepatocellular Carcinoma, and Specific Benefits for Older Adults. In: Clinical Therapeutics. 2018 ; Vol. 40, No. 4. pp. 512-525.
@article{183ab5a6c9804f79a6eac5ceef9bbb1f,
title = "Palliative Care for People With Hepatocellular Carcinoma, and Specific Benefits for Older Adults",
abstract = "Purpose: Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, has a rapidly rising prevalence in the United States and a very poor overall rate of survival. This epidemic is driven by the cohort of aging Baby Boomers with hepatitis C viral infection and the increasing prevalence of cirrhosis as a result of nonalcoholic steatohepatitis. Because curative options are limited, the disease course creates, in patients and their families, distressing uncertainty around prognosis and treatment decisions. Older adults are disproportionately affected by HCC and have more comorbidities, adding to the complexity of the disease. This population would benefit from increased access to palliative care services, which can potentially complement the treatments throughout the disease trajectory. The purpose of this review was to use existing evidence to propose a new model of palliative care integration in patients with HCC. Thus, we focus on the HCC stage and the treatment algorithm, the ways that palliative care can offer support in this population at each stage, as well as elements that can enhance patient and family support throughout the entire disease trajectory, with an emphasis on the care of older adults with HCC. Methods: This is a narrative review in which we identify evidence-based ways that palliative care can help younger and older adults with HCC and their families, at each stage of HCC and throughout the disease trajectory. Findings: We propose ways to integrate HCC and palliative care based on the existing evidence in both fields. Palliative care offers support in symptom management, advanced care planning, and decision making in ways that are specific to each stage of HCC. We also discuss the evidence that illustrates the palliative care needs of patients with HCC that span the entire course of illness, including coping with the stigmatization of liver disease, addressing informational needs at different stages, and discussing quality of life longitudinally. Implications: Integrating palliative care into the treatment of patients with HCC has the potential to improve outcomes, although more research is needed to build this evidence base.",
keywords = "cirrhosis, geriatric oncology, hepatocellular carcinoma, palliative care, supportive oncology",
author = "Woodrell, {Christopher D.} and Lissi Hansen and Schiano, {Thomas D.} and Goldstein, {Nathan E.}",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/j.clinthera.2018.02.017",
language = "English (US)",
volume = "40",
pages = "512--525",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica",
number = "4",

}

TY - JOUR

T1 - Palliative Care for People With Hepatocellular Carcinoma, and Specific Benefits for Older Adults

AU - Woodrell, Christopher D.

AU - Hansen, Lissi

AU - Schiano, Thomas D.

AU - Goldstein, Nathan E.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Purpose: Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, has a rapidly rising prevalence in the United States and a very poor overall rate of survival. This epidemic is driven by the cohort of aging Baby Boomers with hepatitis C viral infection and the increasing prevalence of cirrhosis as a result of nonalcoholic steatohepatitis. Because curative options are limited, the disease course creates, in patients and their families, distressing uncertainty around prognosis and treatment decisions. Older adults are disproportionately affected by HCC and have more comorbidities, adding to the complexity of the disease. This population would benefit from increased access to palliative care services, which can potentially complement the treatments throughout the disease trajectory. The purpose of this review was to use existing evidence to propose a new model of palliative care integration in patients with HCC. Thus, we focus on the HCC stage and the treatment algorithm, the ways that palliative care can offer support in this population at each stage, as well as elements that can enhance patient and family support throughout the entire disease trajectory, with an emphasis on the care of older adults with HCC. Methods: This is a narrative review in which we identify evidence-based ways that palliative care can help younger and older adults with HCC and their families, at each stage of HCC and throughout the disease trajectory. Findings: We propose ways to integrate HCC and palliative care based on the existing evidence in both fields. Palliative care offers support in symptom management, advanced care planning, and decision making in ways that are specific to each stage of HCC. We also discuss the evidence that illustrates the palliative care needs of patients with HCC that span the entire course of illness, including coping with the stigmatization of liver disease, addressing informational needs at different stages, and discussing quality of life longitudinally. Implications: Integrating palliative care into the treatment of patients with HCC has the potential to improve outcomes, although more research is needed to build this evidence base.

AB - Purpose: Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, has a rapidly rising prevalence in the United States and a very poor overall rate of survival. This epidemic is driven by the cohort of aging Baby Boomers with hepatitis C viral infection and the increasing prevalence of cirrhosis as a result of nonalcoholic steatohepatitis. Because curative options are limited, the disease course creates, in patients and their families, distressing uncertainty around prognosis and treatment decisions. Older adults are disproportionately affected by HCC and have more comorbidities, adding to the complexity of the disease. This population would benefit from increased access to palliative care services, which can potentially complement the treatments throughout the disease trajectory. The purpose of this review was to use existing evidence to propose a new model of palliative care integration in patients with HCC. Thus, we focus on the HCC stage and the treatment algorithm, the ways that palliative care can offer support in this population at each stage, as well as elements that can enhance patient and family support throughout the entire disease trajectory, with an emphasis on the care of older adults with HCC. Methods: This is a narrative review in which we identify evidence-based ways that palliative care can help younger and older adults with HCC and their families, at each stage of HCC and throughout the disease trajectory. Findings: We propose ways to integrate HCC and palliative care based on the existing evidence in both fields. Palliative care offers support in symptom management, advanced care planning, and decision making in ways that are specific to each stage of HCC. We also discuss the evidence that illustrates the palliative care needs of patients with HCC that span the entire course of illness, including coping with the stigmatization of liver disease, addressing informational needs at different stages, and discussing quality of life longitudinally. Implications: Integrating palliative care into the treatment of patients with HCC has the potential to improve outcomes, although more research is needed to build this evidence base.

KW - cirrhosis

KW - geriatric oncology

KW - hepatocellular carcinoma

KW - palliative care

KW - supportive oncology

UR - http://www.scopus.com/inward/record.url?scp=85044113667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044113667&partnerID=8YFLogxK

U2 - 10.1016/j.clinthera.2018.02.017

DO - 10.1016/j.clinthera.2018.02.017

M3 - Review article

VL - 40

SP - 512

EP - 525

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - 4

ER -